NEW YORK, June 8, 2017 /PRNewswire/ --
On Wednesday, the New York
headquartered NASDAQ Composite ended the day at 6,297.38, up 0.36%;
the Dow Jones Industrial Average edged 0.18% higher, to finish at
21,173.69; and the S&P 500 closed at 2,433.14, slightly gaining
0.16%. Gains were broad based as six out of nine sectors finished
the trading session in green. DailyStockTracker.com has initiated
research reports on the following Healthcare stocks: Palatin
Technologies Inc. (NYSE MKT: PTN), Centene Corp. (NYSE: CNC),
Anthem Inc. (NYSE: ANTM), and AMAG Pharmaceuticals Inc. (NASDAQ:
AMAG). Daily Stock Tracker published comprehensive and free
research reports on these stocks today at:
http://dailystocktracker.com/register/
Palatin Technologies
Cranbury, New Jersey-based
Palatin Technologies Inc.'s stock finished Wednesday's session
1.96% lower at $0.35 with a total
trading volume of 732,361 shares. The Company's shares have
advanced 2.97% in the previous three months. The stock is trading
7.79% below its 50-day moving average. Additionally, shares of
Palatin Technologies, which develops targeted, receptor-specific
peptide therapeutics for the treatment of various diseases in the
US, have a Relative Strength Index (RSI) of 42.24. PTN complete
research report is just a click away and free at:
http://dailystocktracker.com/registration/?symbol=PTN
Centene
On Wednesday, shares in St. Louis,
Missouri headquartered Centene Corp. recorded a trading
volume of 1.43 million shares. The stock ended the session 1.82%
higher at $77.62. The Company's
shares have advanced 2.41% in the last one month, 10.51% in the
previous three months, and 37.36% on an YTD basis. The stock is
trading 5.48% above its 50-day moving average and 17.34% above its
200-day moving average. Moreover, shares of Centene, which operates
as a diversified and multi-national healthcare enterprise that
provides programs and services to under-insured and uninsured
individuals in the US, have an RSI of 63.29.
On June 07th, 2017,
research firm Morgan Stanley initiated an 'Overweight' rating on
the Company's stock. The complimentary report on CNC can be
downloaded at:
http://dailystocktracker.com/registration/?symbol=CNC
Anthem
Indianapolis, Indiana
headquartered Anthem Inc.'s shares closed the day 0.36% higher at
$188.33. The stock recorded a trading
volume of 1.58 million shares, which was higher than its three
months average volume of 1.45 million shares. The Company's shares
have gained 4.73% in the last month, 13.69% over the previous three
months, and 30.99% on an YTD basis. The stock is trading 7.73% and
25.55% above its 50-day and 200-day moving averages, respectively.
Additionally, shares of Anthem, which through its subsidiaries,
operates as a health benefits company in the US, have an RSI of
71.22.
On June 07th, 2017,
research firm Morgan Stanley initiated an 'Equal-Weight' rating on
the Company's stock. Sign up for your complimentary research report
on ANTM at:
http://dailystocktracker.com/registration/?symbol=ANTM
AMAG Pharma
Shares in Waltham,
Massachusetts headquartered AMAG Pharmaceuticals Inc.
finished 2.99% lower at $16.25. The
stock recorded a trading volume of 1.00 million shares. The
Company's shares are trading below their 50-day moving average by
22.35%. Furthermore, shares of AMAG Pharma, which manufactures,
develops, and commercializes therapeutics for women's health,
anemia management, and cancer supportive care in the US, have an
RSI of 32.10. Get free access to your research report on AMAG
at:
http://dailystocktracker.com/registration/?symbol=AMAG
--
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. DST has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
DST has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer") represented by a
credentialed financial analyst [for further information on analyst
credentials, please email contact@dailystocktracker.com.
Rohit Tuli, a CFA® charterholder
(the "Sponsor"), provides necessary guidance in preparing the
document templates. The Reviewer has reviewed and revised the
content, as necessary, based on publicly available information
which is believed to be reliable. Content is researched, written
and reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to
validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author
according to the procedures outlined by DST. DST is not entitled to
veto or interfere in the application of such procedures by the
third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content
outside of this document has no association with the Author or the
Reviewer in any way.
NO WARRANTY
DST, the Author, and the Reviewer are not responsible for any
error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is
accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. DST, the Author, and the
Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, DST, the Author, and the Reviewer do not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither DST nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://dailystocktracker.com/disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly.
If you're a company we are
covering and wish to no longer feature on our coverage list contact
us via email and/or phone between 09:30 EDT
to 16:00 EDT from Monday to Friday at:
Email: contact@dailystocktracker.com
Phone number: (207) 331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Chelmsford Park SA